WHO Prequalifies Novel Oral Polio Vaccine Type 2 (nOPV2)

On 13th February 2026, the World Health Organization (WHO) prequalified a new novel oral polio vaccine type 2 (nOPV2) to accelerate global polio eradication efforts.

  • Confirms the vaccine meets international standards of quality, safety, and efficacy, enabling procurement by UN agencies like UNICEF for immunisation campaigns.
  • The nOPV2 vaccine is designed to be more genetically stable than earlier oral polio vaccines, reducing the risk of triggering new outbreaks.
  • Supports global campaigns to stop virus transmission and protect children in vulnerable regions.
  • Follows a $1.9 billion pledge by global leaders to sustain eradication initiatives and protect around 370 million children annually.
  • Polio is a disabling and ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy April 2026 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content